These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2908722)

  • 1. T-1583 and forskolin are similar in their cardiac effects and dissimilar in their vascular effects.
    Hosono M; Satoh K; Taira N
    Cardiovasc Drugs Ther; 1988 Jul; 2(2):245-53. PubMed ID: 2908722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of cardiovascular effects of NKH477, a novel forskolin derivative, assessed in isolated, blood-perfused dog heart preparations: comparison with isoproterenol.
    Ishizuka O; Hosono M; Nakamura K
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):261-7. PubMed ID: 1381017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
    Ishimori T; Gotanda K; Sasaki T; Shinbo A; Asano H; Miyazawa K; Miyasaka K
    Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart.
    Imagawa J; Satoh K; Taira N
    Cardiovasc Drugs Ther; 1989 Mar; 3(1):81-90. PubMed ID: 2487526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of alinidine, a bradycardic agent, for SA nodal automaticity versus other cardiac activities in isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):88-102. PubMed ID: 6517649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation of the coronary vasodilator from the cardiac effects of PN 200-110, a new dihydropyridine calcium antagonist, in the dog heart.
    Wada Y; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1985; 7(1):190-6. PubMed ID: 2580142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, on isolated, blood-perfused dog-heart preparations.
    Wada Y; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1984; 6(5):881-7. PubMed ID: 6209495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of cardiovascular profiles of milrinone and amrinone by use of isolated, blood-perfused dog heart preparations.
    Sato Y; Wada Y; Taira N
    Heart Vessels; 1986; 2(4):213-20. PubMed ID: 3571104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inotropic versus chronotropic, dromotropic, and coronary vasodilator actions of DPI 201-106, a novel positive inotropic agent, in the dog heart.
    Takahashi K; Endoh M; Taira N
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):451-60. PubMed ID: 2438508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac and coronary vasodilator effects of the novel cardiotonic agent, MCI-154, assessed in isolated, blood-perfused dog heart preparations.
    Hosono M; Taira N
    J Cardiovasc Pharmacol; 1987 Dec; 10(6):692-8. PubMed ID: 2450240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac and coronary vasodilator profile of pimobendan, a new cardiotonic drug, revealed by use of isolated, blood-perfused dog heart preparations.
    Imagawa J; Satoh K; Taira N
    Heart Vessels; 1987; 3(4):182-9. PubMed ID: 3453824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac versus coronary vasodilator actions of isobutylmethylxanthine in dogs: comparison with theophylline.
    Takahashi K; Wada Y; Taira N
    Jpn J Pharmacol; 1986 May; 41(1):23-32. PubMed ID: 2426501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the cardiovascular and biochemical profiles of a new positive inotropic drug, AR-L 115 BS, with those of theophylline.
    Morita T; Satoh K; Taira N
    Jpn Heart J; 1984 May; 25(3):447-60. PubMed ID: 6088829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac versus coronary dilator effects of SD-3211, a new nondihydropyridine calcium antagonist, in isolated, blood-perfused dog hearts.
    Yoneyama F; Yamada H; Satoh K; Taira N
    Cardiovasc Drugs Ther; 1990 Dec; 4(6):1469-76. PubMed ID: 2081139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac versus coronary vasodilator actions of KB-944, a new calcium antagonist, assessed in isolated, blood-perfused heart preparations of dogs.
    Taira N; Kawada M; Satoh K
    J Cardiovasc Pharmacol; 1983; 5(3):349-56. PubMed ID: 6191131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of MDL 17043 and MDL 19205, new positive inotropic agents, by use of isolated, blood-perfused dog-heart preparations.
    Wada Y; Taira N
    Heart Vessels; 1986; 2(1):29-35. PubMed ID: 2941407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of coronary vasodilator and cardiac actions of bepridil revealed by use of isolated, blood-perfused heart preparations of the dog.
    Kawada M; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1983; 5(4):604-12. PubMed ID: 6193358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart.
    Taira N; Endoh M; Iijima T; Satoh K; Yanagisawa T; Yamashita S; Maruyama M; Kawada M; Morita T; Wada Y
    Arzneimittelforschung; 1984; 34(3A):347-55. PubMed ID: 6331465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the cardiovascular profile of BRL 34915 characteristic of potassium channel activators?
    Gotanda K; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):239-46. PubMed ID: 2459556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dopamine on sinus rate and ventricular contractile force of the dog heart in vitro and in vivo.
    Endoh M
    Br J Pharmacol; 1975 Dec; 55(4):475-86. PubMed ID: 1212559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.